Article Text
Therapeutics
DANAMI-2 randomised controlled trial
Primary percutaneous coronary intervention in ST-segment elevation myocardial infarction is more effective than fibrinolysis at reducing the composite outcome of death or reinfarction after 8 years
Statistics from Altmetric.com
Footnotes
-
Competing interests AED received moderate grant support from PDL Biopharma for the AMICO trial.